ArticleHeliyon2022

Corrigendum to "Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment" [Heliyon 8 (9) (2022) e10694].

Ruswanto Ruswanto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.